Form 8-K - Current report:
SEC Accession No. 0001724521-25-000066
Filing Date
2025-06-02
Accepted
2025-06-02 08:25:32
Documents
12
Period of Report
2025-06-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20250601.htm   iXBRL 8-K 29906
  Complete submission text file 0001724521-25-000066.txt   144761

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20250601.xsd EX-101.SCH 1773
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20250601_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20250601_pre.xml EX-101.PRE 12502
14 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20250601_htm.xml XML 2714
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 251013206
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)